首页|期刊导航|中华医学杂志（英文版）|Association of anti-phospholipase A2 receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy:a prospective,cohort clinical study

Association of anti-phospholipase A2 receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy:a prospective,cohort clinical study

Xian-Wen Zhang Xiao-Xia Liu Jun Yong Li-Feng Wei Chun-Yan Ling Yu Jin Yi-Ping Chen Lin Wang

中华医学杂志（英文版）2021，Vol.134Issue(18)：2252-2254,3.

中华医学杂志（英文版）2021，Vol.134Issue(18)：2252-2254,3.DOI:10.1097/CM9.0000000000001565

Association of anti-phospholipase A2 receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy:a prospective,cohort clinical study

Xian-Wen Zhang ¹Xiao-Xia Liu ²Jun Yong ¹Li-Feng Wei ¹Chun-Yan Ling ¹Yu Jin ³Yi-Ping Chen ¹Lin Wang¹

作者信息

1. Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China
2. Shanghai Minhang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai 200241,China
3. Engineering Research Center of Pharmaceutical Engineering and Process Chemistry,Ministry of Education,School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China
折叠

摘要

引用本文复制引用

Xian-Wen Zhang,Xiao-Xia Liu,Jun Yong,Li-Feng Wei,Chun-Yan Ling,Yu Jin,Yi-Ping Chen,Lin Wang..Association of anti-phospholipase A2 receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy:a prospective,cohort clinical study[J].中华医学杂志（英文版）,2021,134(18):2252-2254,3.

基金项目

The research is supported by grants from the "3-Year Action Plan of Shanghai to Further Speed Up the Development of Traditional Chinese Medicine" (Nos.ZY[2018-2020]-FWTX-6025 （）

ZY[2018-2020]-ZYBZ-02). （）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航